Research Article| Volume 12, ISSUE 4, P669-683, December 1992

Donor Screening

  • Arthur J. Silvergleid
    Address reprint requests to: Arthur J. Silvergleid, MD, Medical and Executive Director, Blood Bank of San Bernardino and Riverside Counties, 384 Orange Show Road, San Bernardino, CA 92408
    From the Department of Medicine, University of California School of Medicine, Los Angeles

    Blood Bank of San Bernardino and Riverside Counties, San Bernardino, California
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      The primary goals of donor screening are to protect the recipient and safeguard the donor. These goals are accomplished through a variety of techniques, the most important of which is the donor medical history interview. This article reviews all elements of predonation donor screening, including donor education, the medical history interview, and the confidential unit exclusion procedure. Specific guidelines, including a proposed national
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Centers for Disease Control
        HIV-infection prevention messages for injecting drug users: Sources of information and use of mass media—Baltimore, 1989.
        MMWR. 1991; 40: 465-469
        • Cleary P.D.
        • Singer E.
        • Rogers T.F.
        • et al.
        Sociodemographic and behavioral characteristics of HIV antibody-positive blood donors.
        Am J Public Health. 1988; 78: 953-957
      1. Food and Drug Administration (OBRR memo to registered blood establishments): Deferral of donors who have received human pituitary/derived growth hormone. Bethesda, November 25, 1987

      2. Food and Drug Administration (CBER memo to facilities preparing platelets, pheresis): Revised guideline for the collection of platelets, pheresis. Bethesda, October 7, 1988

      3. Food and Drug Administration (OBRR memo to registered blood establishments): Revised recommendations for the prevention of human immunodeficiency virus (HIV) transmission by blood and blood products—Section I, Parts A & B only. Bethesda, December 5, 1990

      4. Food and Drug Administration (CBER memo to registered blood establishments): Revised recommendations for the prevention of human immunodeficiency virus (HIV) transmission by blood and blood products. Bethesda, April 23, 1992

        • Guernsey B.G.
        • Patten E.
        • Fuchs Jr, J.E.
        • et al.
        Drug use and blood donor acceptability guide. Cutter Biological, Oakland, CA1983
        • Kirchhoff L.V.
        Is Trypanosoma cruzi a new threat to our blood supply?.
        Ann Intern Med. 1989; 111: 773-775
        • Kolins J.
        • Silvergleid A.J.
        Creating a uniform donor medical history questionnaire.
        Transfusion. 1991; 31: 349-354
        • Loiacano B.
        • Carter G.
        • Leitman S.F.
        • et al.
        Efficacy of various methods of confidential unit exclusion in identifying potentially infectious blood products [abstract].
        Transfusion. 1988; 28 (suppl): 54S
        • Mayo D.J.
        • Rose A.M.
        • Matchett S.E.
        • et al.
        Screening potential blood donors at risk for human immunodeficiency virus.
        Transfusion. 1991; 31: 466-474
        • Perkins H.A.
        • Samson S.
        • Busch M.P.
        How well has self-exclusion worked?.
        Transfusion. 1988; 28: 601-602
        • Pindyck J.
        • Waldman A.
        • Zang E.
        • et al.
        Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion: Evidence of volunteer blood donor cooperation.
        Transfusion. 1985; 25: 3-9
        • Popovsky M.A.
        • Lindberg L.E.
        • Syrek A.L.
        • et al.
        Prevalence of babesia antibody in a selected blood donor population.
        Transfusion. 1988; 28: 59-61
        • Schmidt P.J.
        Blood donation by the healthy elderly [editorial].
        Transfusion. 1991; 31: 681-683
        • Schorr J.B.
        • Berkowitz A.
        • Cummings P.D.
        • et al.
        Prevalence of HTLV-III antibody in American blood donors [letter].
        N Engl J Med. 1985; 313: 384-385
        • Silvergleid A.J.
        Safety and effectiveness of predeposit autologous transfusions in preteen and adolescent children.
        JAMA. 1987; 257: 3403-3404
        • Silvergleid A.J.
        • Leparc G.F.
        • Schmidt P.J.
        Impact of explicit questions about high-risk activities on donor attitudes and donor deferral patterns: Results in two community blood centers.
        Transfusion. 1989; 29: 362-364
        • Skolniek A.
        Does influx from endemic areas mean more transfusion-associated Chagas’ disease?.
        JAMA. 1989; 262: 1433
        • Tipple M.A.
        • Bland L.A.
        • Murphy M.J.
        • et al.
        Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica..
        Transfusion. 1990; 30: 207-213
        • US Department of Health and Human Services, Food and Drug Administration
        The code of federal regulations, 21 CFR 640.65, current edition. US Government Printing Office, Washington, DC1991
        • Ward J.W.
        • Kleinman S.H.
        • Douglas D.K.
        • et al.
        Epidemiologic characteristics of blood donors with antibody to human immunodeficiency virus.
        Transfusion. 1988; 28: 298-301
      5. Widmann F.K. Standards for Blood Banks and Transfusion Services. ed 14. American Association of Blood Banks, Arlington, VA1991